TMEM120B and osteosarcoma: Higher expression levels of TMEM120B and TMEM147 predicted worse overall survival in patients of the TCGA cohort, while they were not associated with the prognosis of osteosarcoma patients in the GSE16091 cohort (Figures 11E and F).